Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 1/2 4Phase 3 3Phase 1 2Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Waldenstrom Macroglobulinemia 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Cyclophosphamide 4Rituximab 3Vincristine 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Magnetic Resonance Spectroscopy 2Immunotherapy, Adoptive 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Doxorubicin 2tisagenlecleucel 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1oblimersen 1ibritumomab tiuxetan 1duvelisib 1Surveys and Questionnaires 1Sugars 1Specimen Handling 1Radiation 1Pemetrexed 1Nivolumab 1NVP-BKM120 1Microarray Analysis 1Methotrexate 1Loratadine 1Leukapheresis 1Immunohistochemistry 1Gene Expression Profiling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lymphoma, Large B-Cell, Diffuse × ibritumomab tiuxetan × Clear all
NCT00017381 2013-01-09

Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase EARLY_PHASE1 Completed
30 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡